HGH-ALBO A/S — Credit Rating and Financial Key Figures

HGH-ALBO A/S (CVR number: 21594628) is a company from FURESØ. The company reported a net sales of 0.3 mDKK in 2023, demonstrating a growth of 0.4 % compared to the previous year. The operating profit percentage was poor at -1.5 % (EBIT: -0 mDKK), while net earnings were 92.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was 2.9 %, which can be considered weak and Return on Equity (ROE) was 1.9 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 74.8 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. HGH-ALBO A/S's liquidity measured by quick ratio was 6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.